Skip to main content

Table 3 Hazard ratios and 95% confidence intervals of candidate prognostic factors of the multivariable Cox proportional hazards models on overall survival of 417 breast cancer patients of the ISE cohort

From: Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer

 

10-year

Follow-Up

 

15-year

Follow-Up

 

Hazard Ratio (95% CI)

P

Hazard Ratio (95% CI)

P

Global Health Status/Quality of Life* (lowest tertile vs. intermediate and highest tertiles)

1.60 (0.91 to 2.82)

0.10

1.52 (0.97 to 2.37)

0.07

Tumour Size

2.94 (1.65 to 5.25)

< 0.005

1.98 (1.24 to 3.18)

< 0.005

Nodal Involvement

2.64 (1.45 to 4.83)

< 0.005

1.93 (1.16 to 3.21)

0.01

Grading

 

Grade 1

Reference

Grade 2

0.72 (0.33 to 1.57)

0.41

0.80 (0.44 to 1.45)

0.46

Grade 3

0.89 (0.35 to 2.24)

0.81

0.86 (0.41 to 1.80)

0.69

Hormone Receptor Positivity (ER/PR)

0.52 (0.21 to 1.27)

0.15

0.52 (0.26 to 1.05)

0.07

Age

1.04 (1.01 to 1.08)

0.008

1.08 (1.05 to 1.11)

< 0.005

Body Mass Index (kg/m2)

1.06 (0.99 to 1.13)

0.07

1.02 (0.97 to 1.08)

0.39

  1. *Global Health Status/Quality of Life was defined based on standardised scores of the EORTC QLQ-C30 Global Health Status/Quality of Life scale (items 29, 30), with the lowest tertile defined as clinically important impairment and compared with the intermediate and highest tertile